Voltage-gated and leak sodium channels (Nav/NALCN)

Voltage-gated and leak sodium channels are essential transmembrane proteins that mediate the influx of sodium ions, thereby governing the electrical excitability of cells (Catterall, W. A., 2012, PubMed). Voltage-gated sodium channels (Nav1.1–Nav1.9) are primarily responsible for the rapid depolarization phase of action potentials in the nervous system, heart, and skeletal muscle (IUPHAR/BPS Guide to Pharmacology). In contrast, the sodium leak channel (NALCN) is a voltage-independent channel that maintains the resting membrane potential and regulates the tonic firing rates of neuronal networks, particularly those involved in respiratory control (UniProt Q8IZF0; Lu et al., 2007, Nature). Dysregulation or genetic mutations in these channels lead to a variety of channelopathies, including epilepsy, chronic pain syndromes, and life-threatening cardiac arrhythmias (StatPearls, Sodium Channelopathies). Pharmacological agents such as local anesthetics, antiarrhythmics, and anticonvulsants target these channels to suppress aberrant electrical activity (PubChem). However, the high structural similarity between channel subtypes presents a significant challenge for drug development, as non-selective inhibition can lead to severe side effects like cardiotoxicity or neurological impairment.

Other names

Sodium channelsVoltage-dependent sodium channelsSodium leak channel non-selectiveNav channelsNALCNVoltage-gated sodium channel complex

Drugs typically act as pore blockers that physically obstruct the ion conduction pathway or as gating modifiers that stabilize the channel in an inactive state, thereby reducing cellular excitability and preventing high-frequency firing.